On optimal delivery of combination therapy for tumors

DOI10.1016/J.MBS.2009.08.004zbMath1176.92033OpenAlexW2091513278WikidataQ51798408 ScholiaQ51798408MaRDI QIDQ1042733

Heinz Schättler, Helmut Maurer, Alberto d'Onofrio, Urszula Łedzewicz-Kowalewska

Publication date: 7 December 2009

Published in: Mathematical Biosciences (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.mbs.2009.08.004

zbMATH Keywords

optimal controlmathematical modelchemotherapyanti-angiogenesiscombination therapy for tumors

Mathematics Subject Classification ID

Applications of optimal control and differential games (49N90) Medical applications (general) (92C50) Existence theories for optimal control problems involving ordinary differential equations (49J15)

Related Items (61)

Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy ⋮ The stability analysis of tumor-immune responses to chemotherapy system driven by Gaussian colored noises ⋮ Optimal control of vibration-based micro-energy harvesters ⋮ Noise and delay enhanced stability in tumor-immune responses to chemotherapy system ⋮ Dynamics and optimal control of chemotherapy for low grade gliomas: insights from a mathematical model ⋮ A deterministic and stochastic model for the system dynamics of tumor-immune responses to chemotherapy ⋮ Dynamical analysis of chemotherapy models with time-dependent infusion ⋮ Local controllability and optimal control for a model of combined anticancer therapy with control delays ⋮ Optimal Control of Cancer Treatments: Mathematical Models for the Tumor Microenvironment ⋮ Control strategies for a tumor-immune system with impulsive drug delivery under a random environment ⋮ Optimal control of cancer chemotherapy with delays and state constraints ⋮ Optimal chemotherapy schedules from tumor entropy ⋮ Spreading speeds for a two-species competition-diffusion system ⋮ Sensitivity of combined chemo- and antiangiogenic therapy results in different models describing cancer growth ⋮ Mathematical modeling of the immune-chemotherapeutic treatment of breast cancer under some control parameters ⋮ An optimal control problem of immuno-chemotherapy in presence of gene therapy ⋮ Optimization of combined leukemia therapy by finite-dimensional optimal control modeling ⋮ Mathematical modelling for spatial optimization of irradiation during proton radiotherapy with nanosensitizers ⋮ The nature of Hopf bifurcation for the Gompertz model with delays ⋮ Structural stability investigation of bang-singular-bang optimal controls ⋮ Multi-input optimal control problems for combined tumor anti-angiogenic and radiotherapy treatments ⋮ Analysis of the Hopf bifurcation for the family of angiogenesis models. II: The case of two nonzero unequal delays ⋮ Combination of antiangiogenic treatment with chemotherapy as a multi‐input optimal control problem ⋮ Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function ⋮ Stability analysis of the family of tumour angiogenesis models with distributed time delays ⋮ Multi-control commercial aircraft trajectory optimization in a vertical plane with state-inequality constraints via singular control theory ⋮ On strategies on a mathematical model for leukemia therapy ⋮ Optimal control problems for differential equations applied to tumor growth: state of the art ⋮ Stability analysis on a hybrid PDE–ODE system describing intermittent hormonal therapy of prostate cancer ⋮ Tumour growth control: analysis of alternative approaches ⋮ Optimizing the delivery of combination therapy for tumors: A mathematical model ⋮ Closed-loop control of tumor growth by means of anti-angiogenic administration ⋮ Chemotherapy of vascularised tumours: role of vessel density and the effect of vascular ``pruning ⋮ Delay Differential Equations in Bio-Populations ⋮ A survey of optimization models on cancer chemotherapy treatment planning ⋮ Catalog of the optimal controls in cancer chemotherapy for the Gompertz model depending on PK/PD and the integral constraint ⋮ Optimal combined radio- and anti-angiogenic cancer therapy ⋮ Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics ⋮ Passing to the limit 2D–1D in a model for metastatic growth ⋮ Analysis of the effectiveness of the treatment of solid tumors in two cases of drug administration ⋮ Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors ⋮ Optimization of additive chemotherapy combinations for an in vitro cell cycle model with constant drug exposures ⋮ Maximization of viability time in a mathematical model of cancer therapy ⋮ Stochastic modelling of slow-progressing tumors: analysis and applications to the cell interplay and control of low grade gliomas ⋮ A generalization of Gompertz law compatible with the Gyllenberg-Webb theory for tumour growth ⋮ Analysis of the Hopf bifurcation for the family of angiogenesis models ⋮ Optimization of an \textit{in vitro} chemotherapy to avoid resistant tumours ⋮ On the role of the objective in the optimization of compartmental models for biomedical therapies ⋮ On the role of pharmacometrics in mathematical models for cancer treatments ⋮ Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers ⋮ Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors ⋮ On probabilistic certification of combined cancer therapies using strongly uncertain models ⋮ Optimisation of Cancer Drug Treatments Using Cell Population Dynamics ⋮ Tumor Development Under Combination Treatments with Anti-angiogenic Therapies ⋮ Therapy strategy in tumour cells and immune system interaction mathematical model ⋮ Qualitative analysis of tumor growth model under antiangiogenic therapy - choosing the effective operating point and design parameters for controller design ⋮ Optimal control for a mathematical model for chemotherapy with pharmacometrics ⋮ Effect of treatment on the global dynamics of delayed pathological angiogenesis models ⋮ Analyzing the quality robustness of chemotherapy plans with respect to model uncertainties ⋮ On the preliminary design of hyperthermia treatments based on infusion and heating of magnetic nanofluids ⋮ Unnamed Item

Cites Work

• Unnamed Item
• Unnamed Item
• Unnamed Item
• Unnamed Item
• Unnamed Item
• Unnamed Item
• Optimal scheduling of radiotherapy and angiogenic inhibitors
• Optimal control in a model of dendritic cell transfection cancer immunotherapy
• Critical-point analysis for three-variable cancer angiogenesis models
• Tutorials in mathematical biosciences III. Cell cycle, prolifereation, and cancer.
• Scheduling of angiogenic inhibitors for Gompertzian and logistic tumor growth models
• The response to antiangiogenic anticancer drugs that inhibit endothelial cell proliferation
• Multiscale modelling of tumour growth and therapy: the influence of vessel normalisation on chemotherapy
• Role of optimal control theory in cancer chemotherapy
• Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemo\-therapy
• Stochastic modelling of tumour-induced angiogenesis
• On the optimality of singular controls for a class of mathematical models for tumor anti-angiogenesis
• Continuous and discrete mathematical models of tumor-induced angiogenesis
• Optimal control of the chemotherapy of HIV
• SQP-methods for solving optimal control problems with control and state constraints: Adjoint variables, sensitivity analysis and real-time control
• Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis
• Singular trajectories and their role in control theory
• Optimal bang-bang controls for a two-compartment model in cancer chemotherapy
• Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)
• Vascular network remodeling via vessel cooption, regression and growth in tumors
• A bi-parametric model for the tumour angiogenesis and antiangiogenesis therapy
• Modelling the role of angiogenesis and vasculogenesis in solid tumour growth
• A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences
• A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
• AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
• Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment
• A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy
• Optimal Control Applied to Cell-Cycle-Specific Cancer Chemotherapy
• ANALYSIS OF A CELL-CYCLE SPECIFIC MODEL FOR CANCER CHEMOTHERAPY
• Simple ODE models of tumor growth and anti-angiogenic or radiation treatment

This page was built for publication: On optimal delivery of combination therapy for tumors